[Drug treatment of postmenopausal osteoporosis. What's New in 2006].
Roux
Christian
C
Service de rhumatologie, Hôpital Cochin, Paris (75).
Briot
Karine
K
Dumarcet
Nathalie
N
Bourgoin
Michel
M
Chapurlat
Roland
R
Christin-Maitre
Sophie
S
Cortet
Bernard
B
Costagliola
Dominique
D
Diebolt
Vincent
V
Lacoin
François
F
Letombe
Brigitte
B
Oberlin
Flavien
F
Orcel
Philippe
P
Ravaud
Philippe
P
Seret
Patrick
P
Thomas
Thierry
T
Vogel
Jean-Yves
JY
Barna
Alexandre
A
Nouyrigat
Emmanuel
E
Veyries
Marie-Laure
ML
Yoldjian
Isabelle
I
D015502:Absorptiometry, Photon; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D019386:Alendronate / Q000008:administration & dosage / Q000627:therapeutic use; D015992:Body Mass Index; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001851:Bone Diseases, Metabolic / Q000175:diagnosis / Q000628:therapy; D005260:Female; D005264:Femoral Fractures / Q000209:etiology / Q000517:prevention & control; D005500:Follow-Up Studies; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D016103:Spinal Fractures / Q000209:etiology / Q000517:prevention & control; D013607:Tablets; D019379:Teriparatide / Q000008:administration & dosage / Q000627:therapeutic use; D013876:Thiophenes / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D050071:Bone Density Conservation Agents; D009942:Organometallic Compounds; D013607:Tablets; D013876:Thiophenes; C081587:strontium ranelate; D019379:Teriparatide; D020849:Raloxifene Hydrochloride; D019386:Alendronate